Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Esquire Financial | ESQ | Nov 22, 2024 | 76.50 | +3.38 |
ESS Tech | GWH | Nov 22, 2024 | 6.00 | +15.61 |
ESSA Bancorp | ESSA | Nov 22, 2024 | 20.30 | +0.74 |
ESSA Pharma | EPIX | Nov 22, 2024 | 1.83 | +3.98 |
Essent Group | ESNT | Nov 22, 2024 | 56.76 | +1.48 |
Essential Properties Realty Trust | EPRT | Nov 22, 2024 | 33.47 | -0.09 |
Essential Utilities | WTRG | Nov 22, 2024 | 39.53 | +0.43 |
Essex Property Trust | ESS | Nov 22, 2024 | 305.53 | +0.39 |
Establishment Labs | ESTA | Nov 22, 2024 | 43.08 | +1.10 |
Estee Lauder Companies | EL | Nov 22, 2024 | 69.93 | +4.62 |
Estrella Immunopharma | ESLA | Nov 22, 2024 | 0.91 | +2.25 |
Eterna Therapeutics | ERNA | Nov 22, 2024 | 0.52 | -2.29 |
ETFMG Alternative Harvest ETF | MJ | Nov 22, 2024 | 2.52 | -0.79 |
Ethan Allen Interiors | ETD | Nov 22, 2024 | 29.93 | +2.12 |
Eton Pharmaceuticals | ETON | Nov 22, 2024 | 11.23 | +4.47 |
Etsy | ETSY | Nov 22, 2024 | 52.30 | +0.60 |
Euda Health | EUDA | Nov 22, 2024 | 4.53 | -3.00 |
Eupraxia Pharmaceuticals | EPRX | Nov 22, 2024 | 3.49 | +3.56 |
Eureka Acquisition | EURK | Nov 22, 2024 | 10.12 | 0.00 |
Eureka Acquisition | EURKU | Nov 22, 2024 | 10.29 | 0.00 |
Euro Tech Holdings | CLWT | Nov 22, 2024 | 1.43 | -1.38 |
Euro Trust | FXE | Nov 22, 2024 | 96.18 | -0.60 |
EuroDry | EDRY | Nov 22, 2024 | 14.10 | -2.13 |
Euronav | EURN | Nov 22, 2024 | 16.31 | 0.00 |
Euronav | CMBT | Nov 22, 2024 | 11.76 | -0.68 |
Euronet Worldwide | EEFT | Nov 22, 2024 | 105.51 | +0.56 |
Europe Alphadex First Trust | FEP | Nov 22, 2024 | 36.34 | -0.27 |
Europe ETF FTSE Vanguard | VGK | Nov 22, 2024 | 64.81 | +0.37 |
Europe Financials Index MSCI Ishares | EUFN | Nov 22, 2024 | 23.44 | -0.89 |
Europe Smallcap Dividend Wisdomtree | DFE | Nov 22, 2024 | 57.18 | +0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.